Frequency of hyperostosis frontalis interna in patients with active acromegaly: is there a possible role of GH excess or hyperprolactinemia in its etiopathogenesis?-Reference-Cited by-同舟云学术

Frequency of hyperostosis frontalis interna in patients with active acromegaly: is there a possible role of GH excess or hyperprolactinemia in its etiopathogenesis?

Published:2022-10-12 Issue:1 Volume:22 Page:25-32
ISSN:1109-3099
Container-title:Hormones
language:en
Short-container-title:Hormones

Author:

Mutlu Ummu^ORCID,Telci Caklili Ozge^ORCID,Barburoglu Mehmet^ORCID,Yarman Sema^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s42000-022-00401-x.pdf

Reference42 articles.

1. Mazziotti G, Maffezzoni F, Frara S, Giustina A (2017) Acromegalic osteopathy. Pituitary 20(1):63–69. https://doi.org/10.1007/s11102-016-0758-6

2. Mulhern DM, Wilczak CA, Dudar JCh (2006) Brief communication: unusual finding at Pueblo Bonito: multiple cases of hyperostosis frontalis interna. Am J Phys Anthropol 130:480–484. https://doi.org/10.1002/ajpa.20396

3. Moore S (1936) Calvarial hyperostosis and the accompanying symptom complex. Arch Neurol Psychiatr 35(5):975–981. https://doi.org/10.1001/archneurpsyc.1936.02260050049003

4. Nallegowda M, Singh U, Khanna M, Yadav SL, Choudhary AR, Thakar A (2005) Morgagni Stewart Morel syndrome–additional features. Neurol India 53:117. https://doi.org/10.4103/0028-3886.15078

5. She R, Szakacs J (2004) Hyperostosis frontalis interna: case report and review of literature. Ann Clin Lab Sci 34:206–208. https://doi.org/10.1159/000105609

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pronounced hyperostosis frontalis interna and co‐occurring lesions in the skull base suggestive of a pituitary tumor in a woman from medieval Germany;International Journal of Osteoarchaeology;2023-10-19

2. COVID-19, diabetes mellitus type 2, endocrine genetics, and pituitary and adrenal diseases;Hormones;2023-03